GGrantIndex
← Leaderboards

Qun Lu

East Carolina University

$4,800,371
Attributed
$4,800,371
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $825.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,800,371 · 4

By mechanism

R01$4,180,726 · 2
R15$499,943 · 1
R03$119,702 · 1

Top collaborators

No co-investigators on record.

Most similar at East Carolina University

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionFamilyComplexEventInsightProteinsMonomeric Gtp-Binding ProteinsAreaPharmaceutical PreparationsExhibitsSignal PathwaySmall MoleculeRelating To Nervous SystemMouse ModelRho Gtp-Binding ProteinsInnovationChronic DiseaseAffectAmyotrophic Lateral SclerosisChronicGene ExpressionHuman DiseaseBiological ProcessCell Motility

Grant awards (16)

Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$677,409
R01 · FY2025 · GM · contact PI
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$677,409
R01 · FY2024 · GM · contact PI
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$510,545
R01 · FY2023 · GM · contact PI
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$315,044
R01 · FY2023 · GM · contact PI
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$1
R01 · FY2023 · GM · contact PI
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$614,368
R01 · FY2022 · GM · contact PI
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases$627,118
R01 · FY2021 · GM · contact PI
Rho GTPases and Neuroprotection Model in Cancer Therapy$78,377
R15 · FY2014 · CA · contact PI
Rho GTPases and Neuroprotection Model in Cancer Therapy$421,566
R15 · FY2012 · CA · contact PI
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer$17,220
R01 · FY2010 · CA · contact PI
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer$184,029
R01 · FY2009 · CA · contact PI
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer$184,029
R01 · FY2008 · CA · contact PI
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer$184,029
R01 · FY2007 · CA · contact PI
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer$189,525
R01 · FY2006 · CA · contact PI
Delta-Catenin Cleavage by Presenilin and Synaptic Remodeling$59,139
R03 · FY2006 · AG · contact PI
Delta-Catenin Cleavage by Presenilin and Synaptic Remodeling$60,563
R03 · FY2005 · AG